PillRx only · Suppository · Rectal
Mesalamine
Brands: Canasa · Mesalamine
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
8 active makers
8 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$5.778
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
8
Active US suppliers
43%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
11K
Rx · 2026 Q1
386K
Units dispensed
+8%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it8 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Rising Pharma Holdings, Inc. | unknown | 3 | SUPPLYING |
| Allergan, Inc. | unknown | 3 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Amring Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| NorthStar Rx LLC | unknown | 1 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 1 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 1 | EXITED 2026 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.